| | | | | Economic 'storms' can aid ophthalmologic practices in the future
| | | Now is the time to focus on the lessons that can be learned in the current economic situation. Take a close look at your staffing levels, practices within your office, and the effect of days spent out of clinic by physicians, among other things, to try to identify ways to weather bad economic times better in the future.
| | | MBA: Is this the right decision for me?
| | | Many, if not most, ophthalmologists have at least entertained the idea of obtaining a master of business administration degree. This three-part series is designed to provide guidance through the process. The first steps involve the realization of goals, the return on investment, and the application process.
| | | How to cut costs without cutting staff
| | | The recession has affected medical practices, causing many to look at how money is spent. This five-partner practice cuts expenses creatively by not overlooking small details and has been able to prevent employee layoffs.
| |
| | | | FDA resumes review of toric implantable contact lens
| | | By
Ophthalmology Times Staff Reports
| | | The FDA will resume scientific review of the STAAR Surgical Co. premarket approval (PMA) application for its toric implantable contact lens ([TICL]; Visian Toric Implantable Collamer Lens) for patients with myopia and astigmatism after removing the "integrity hold" restrictions it put in place in 2007, according to the company.
| |
| | | | | | | | | | Analysis: Competency-based model to take over graduate medical education
| | | By
Andrew G. Lee, MD
| | | The apprenticeship model suffers from inherent limitations that have called into question not only the safety but the quality, appropriateness, and effectiveness of the training model for residents. External stakeholders in the educational process, including the public, the payers, and the government, have called for reform in the graduate medical education process and for transformation from the apprenticeship model to a competency-based model of education.
| |
| | | | Kill kinetics of advanced-generation fluoroquinolones compared in study
| | | By
Cheryl Guttman
| | | An in vitro kill kinetics study evaluated eradication of 18 human ocular Staphylococcus isolates by commercial formulations of gatifloxacin 0.3% (Zymar, Allergan) and moxifloxacin 0.5% (Vigamox, Alcon Laboratories). Gatifloxacin demonstrated superior activity, which may be attributed to the presence of benzalkonium chloride 0.005% in its formulation.
| | | Fourth-generation fluoroquinolone widens the choice of antibiotic
| | | By
Cheryl Guttman
| | | The introduction of a new fourth-generation fluoroquinolone for ophthalmic use may prompt an assessment of the pros and cons of the available agents. James P. McCulley, MD, explains his continued preference for moxifloxacin 0.5% (Vigamox, Alcon).
| | | Wine: Enjoy some downtime at a local vineyard
| | | By
Stephanie Skernivitz
| | | Napa and Sonoma counties, located approximately an hour from San Francisco, are well known around the United States and the world for their superior wine and wineries.
| | | Dining: Please your appetite in Bay City
| | | By
Stephanie Skernivitz
| | | San Francisco has cuisine to satisfy many taste buds. From dim sum to gnocchi, use this guide to map out your dining tour of the city by the bay.
| | | Besifloxacin: Fluoroquinolone developed expressly for ophthalmic use
| | | Besifloxacin is the first chlorinated fluoroquinolone developed especially for use in the eye.
| | | San Francisco unmatched as a travel destination
| | | By
Stephanie Skernivitz
| | | San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and household income are among the top in the nation, which enables a profitable restaurant and entertainment scene.
| |
| | | | Vision Expo West: Win big in Vegas
| | | By
Christina Phillis
| | | Vision Expo West takes place from Sept. 30 to Oct. 3 at the Sands Expo and Convention Center, Las Vegas.
| | | Adair Eyewear launches Trendyreaders.com
| | | By
Ophthalmology Times Staff Reports
| | | Adair Eyewear, a family owned eyewear retailer, has launched an online reading glass boutique called TrendyReaders.com.
| | | Pediatric dispensing for any age
| | | From babies to toddlers to pre-teens, there are many important considerations to implement when you are dispensing to kids. These considerations range from toddler eyes that are sensitive to ultraviolet rays to protective eyewear for your budding athlete.
| | | New lens provides high-definition vision benefits
| | | By
Ophthalmology Times Staff Reports
| | | A new lens has been introduced into the market (iZon SL Lenses in Transitions VI, Ophthonix) that provides an ultraviolet-light-activated, changeable tint that can offer many HD vision benefits, including better vision in low luminance and intermediate contrast conditions.
| | | Premium frames give patients originality and high quality
| | | Despite the economy, there still are many patients who will be interested in premium frame collections. With premium frames you can offer patients luxury, technology, and fashion.
| | | Suites at Vision Expo West moving to Palazzo hotel
| | | By
Ophthalmology Times Staff Reports
| | | The Suites at Vision Expo West (VEW) will be moving from the traditional location inside the Venetian Hotel to the new Palazzo Las Vegas.
| |
| | | | | | | Emerging technology aids diabetic retinopathy screening
| | | By
Mark B. Abelson, MD, CM, FRCSC
| | | Ophthalmologists should take a proactive approach toward the screening, management, and early treatment of diabetic retinopathy.
| | | Diabetic macular edema responds to ranibizumab in study
| | | By
Lynda Charters
| | | Diabetic macular edema responds to treatment with ranibizumab (Lucentis, Genentech), according to results of the RESOLVE study. The patient responses to the drug in the changes in the visual acuity and central macular thickness were significantly better in the groups treated with two concentrations of ranibizumab compared with the sham-treated group.
| |
|
|
| 
Practice Tools
